Atlas FDA

Alinity i Anti-HCV

FDA premarket approval P050042/S041 · decided 2020-05-23

Approval details

PMA number
P050042
Supplement
S041
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Alinity i Anti-HCV
Generic name
Assay, enzyme linked immunosorbent, hepatitis c virus
Applicant
Abbott Laboratories, Inc.
Date received
2020-03-16
Decision date
2020-05-23
Days to decision
68 days
Decision code
APPR
Product code
MZO
Advisory committee
Microbiology
Expedited review
No
Location
Abbott Park, IL
Statement
Approval for a manufacturing site located at Abbott Laboratories, 1915 Hurd Drive, Irving, Texas 75038, USA for the production of the Alinity i System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
ARCHITECT IVALPROIC ACID REAGENTS AND ARCHITECT IVALPROIC ACID CALIBRATORS, MODELS 1P35, 1P35 (K090358)Abbott Laboratories, Inc.2009-08-06
CREATININE (K061193)Abbott Laboratories, Inc.2006-06-23
PRECISION XTRA PLUS OR OPTIUM PLUS, BLOOD GLUCOSE TEST STRIPS (K051213)Abbott Laboratories, Inc.2005-05-27
FOX PLUS PTA CATHETER (K040954)Abbott Laboratories, Inc.2004-05-11
AXSYM CYCLOSPORINE (K040761)Abbott Laboratories, Inc.2004-04-30
GEMSTAR INFUSION PUMP SYSTEM, 7 THERAPY, 6 THERAPY & PAIN MANAGEMENT (K023062)Abbott Laboratories, Inc.2002-09-30